Biomatrix (BXM) Looking Great Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: James Baker who wrote (55)	8/27/1997 1:12:00 PM
From: Alex Greenland	of 569

Some more good news: NEW YORK, Aug 27 (Reuter) - Ladenburg Thalmann said analyst Andre Garnet initiated coverage of Biomatrix Inc with a buy rating and a 12-to-18-month price target of $48. -- said company has developed a ``new, simple and inexpensive treatment for osteoarthritis of the knee, Synvisc, that is about to be launched in the U.S. and most large foreign pharmaceutical markets.''

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next